Balchem Co. (NASDAQ:BCPC) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC lowered its position in shares of Balchem Co. (NASDAQ:BCPC) by 8.4% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,880 shares of the basic materials company’s stock after selling 450 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Balchem were worth $859,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in BCPC. Janus Henderson Group PLC grew its holdings in Balchem by 21.3% in the first quarter. Janus Henderson Group PLC now owns 18,059 shares of the basic materials company’s stock valued at $2,795,000 after purchasing an additional 3,176 shares during the last quarter. William Blair Investment Management LLC boosted its position in shares of Balchem by 8.4% in the 2nd quarter. William Blair Investment Management LLC now owns 233,831 shares of the basic materials company’s stock worth $35,998,000 after buying an additional 18,104 shares in the last quarter. Oppenheimer Asset Management Inc. grew its stake in Balchem by 22.1% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 20,582 shares of the basic materials company’s stock valued at $3,169,000 after acquiring an additional 3,732 shares during the last quarter. Fiera Capital Corp purchased a new position in Balchem during the 3rd quarter valued at about $4,201,000. Finally, Envestnet Asset Management Inc. raised its position in Balchem by 9.9% during the second quarter. Envestnet Asset Management Inc. now owns 114,253 shares of the basic materials company’s stock worth $17,589,000 after acquiring an additional 10,285 shares during the last quarter. Institutional investors and hedge funds own 87.91% of the company’s stock.

Balchem Trading Down 0.2 %

BCPC opened at $182.32 on Wednesday. The firm has a market capitalization of $5.93 billion, a P/E ratio of 48.74, a P/E/G ratio of 5.45 and a beta of 0.65. The firm’s 50 day moving average is $174.05 and its 200-day moving average is $166.90. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. Balchem Co. has a 52-week low of $120.87 and a 52-week high of $186.03.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on BCPC. HC Wainwright lifted their price objective on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.